FRANCISCO JAVIER
AMPUDIA BLASCO
PROF. PERMANENTE LABORAL PPL
GlaxoSmithKline (Spain)
Madrid, EspañaGlaxoSmithKline (Spain)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2006
-
Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain
PharmacoEconomics, Vol. 24, Núm. SUPPL. 1, pp. 49-59